eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
lymphoma, Lymphoma: Click to Expand ⟱
Lymphoma is a cancer of the lymphatic system.
|
Scientific Papers found: Click to Expand⟱
eff↓, eff↑, TumVol↓, antiOx↑, Hif1a↓,
| - |
in-vitro, |
lymphoma, |
K562 |
|
|
|
- |
NA, |
NA, |
U937 |
|
|
|
- |
NA, |
NA, |
HL-60 |
|
|
|
Apoptosis↑, eff↑,
| - |
in-vitro, |
lymphoma, |
PEL |
|
|
|
Akt↓, ROS↑, BAX↓, MMP↓, Cyt‑c↑, eff↑, Casp9↑, Casp3↑, cl‑PARP↑, DR5↑,
| - |
in-vitro, |
Colon, |
MC38 |
|
|
|
- |
in-vitro, |
lymphoma, |
L428 |
|
|
|
NF-kB↓, eff↑, eff↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, BAX↓, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, DR5↑, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 2, eff↑, 4,
Functional Outcomes ⓘ
TumVol↓, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:30 Cells:% prod#:% Target#:961 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page